VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: T. Mann who wrote (1953)	8/12/1997 8:15:00 PM
From: A.J. Mullen	of 9719

T., in an earlier post you mentioned you expected Glaxo/Biota anti-flu product would be approved before Aviron. Biota expects to file in late 1998. Can you give me a date for Aviron? The mutation rate of the virus seems to me to be an important strike against Aviron. Also the fact that any flu vaccine will get a bad rap when people get sick after having been immunized. They may be getting sick from something other than flu, but, if it feels like flu, they'll be disappointed in the vaccine. Biota is working on a diagnostic kit.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next